Vidalista 2.5 Centurion Laboratories at a Glance
Vidalista 2.5 is a tadalafil citrate formulation manufactured by Centurion Laboratories for in-vitro research applications. Tadalafil citrate is a selective phosphodiesterase type 5 (PDE5) inhibitor that researchers investigate for its molecular mechanisms in vascular smooth muscle regulation and cyclic guanosine monophosphate (cGMP) pathway modulation. This compound represents a valuable tool for studying cardiovascular pharmacology and cellular signalling pathways in controlled laboratory settings. Each tablet contains precisely measured tadalafil citrate content suitable for analytical research procedures.
Laboratory Applications
Researchers examine tadalafil citrate’s selective inhibition of PDE5 enzymes in cardiovascular tissue models and vascular smooth muscle cell cultures. The compound’s long half-life and molecular stability make it particularly useful for extended incubation studies and time-course experiments. Scientists study its effects on nitric oxide-cGMP signalling cascades, investigating how PDE5 inhibition influences cellular calcium handling and smooth muscle contractility. Research applications include pharmacokinetic studies, enzyme kinetics analysis, and comparative inhibitor profiling against related phosphodiesterase isoforms. Our Stroid UK Shop supports academic institutions conducting cardiovascular research. Laboratories frequently incorporate this compound alongside other PDE5 inhibitor research materials for comprehensive pharmacological studies. Advanced research protocols often combine tadalafil studies with selective androgen receptor modulators and peptide compounds for multi-target pathway analysis.
Specification Data
| Parameter | Value |
|---|---|
| Active Ingredient | Tadalafil Citrate |
| Strength | 2.5mg per tablet |
| Manufacturer | Centurion Laboratories |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Laboratory standard |
Research Compliance
This product is manufactured by Centurion Laboratories exclusively for in-vitro laboratory research purposes. Vidalista 2.5 is intended solely for qualified researchers conducting studies on phosphodiesterase enzyme systems, cardiovascular pharmacology, and cellular signalling mechanisms in controlled laboratory environments. This material is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with institutional guidelines and local regulations governing research chemical handling. All studies should be conducted under appropriate laboratory safety protocols with proper documentation and waste disposal procedures. Purchase and use of this research material indicates acceptance of these terms and acknowledgment of its research-only designation.
